 | Talnetant | Ki | 144.0 [1], 3700.0 [2], 3981.07 [3], 10000.0 [4] |
 | (2S,5S,8R)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 2.0 [1] |
 | Neurokinin A | IC50 | 1.7 [1], 7.7 [2] |
 | Neurokinin A | Ki | 0.71 [1], 1.2 [2] |
 | Saredutant | IC50 | 0.13 [1], 0.44 [2], 0.8 [3] |
 | Saredutant | Ki | 0.5 [1] |
 | Osanetant | Ki | 35.5 [1], 40.3 [2], 79.43 [3], 85.0 [4] |
 | 1-[(4Z)-5-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-3-(3,4-dichlorophenyl)-4-methoxyiminopentyl]-4-phenylpiperidin-4-ol | Ki | 21.0 [1] |
 | Neurokinin B | IC50 | 102.33 [1] |
 | Neurokinin B | Ki | 15.85 [1], 42.2 [2] |
 | Neurokinin A (4-10), nle(10)- | IC50 | 2.5 [1], 3.5 [2], 9.2 [3] |
 | (2S,5S,8R)-5-Benzyl-8-[(3,4-dichlorophenyl)methyl]-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 0.1 [1] |
 | 3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acid | IC50 | 8.0 [1], 8.4 [2] |
 | 3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acid | Ki | 1.0 [1] |
 | Substance P | IC50 | 245.47 [1] |
 | Substance P | Ki | 102.0 [1] |
 | Senktide | IC50 | 10000.0 [1] |
 | Senktide | Ki | 10000.0 [1] |
 | 3,5-Bis(trifluoromethyl)benzyl N-acetyltryptophan | IC50 | 5000.0 [1] |
 | SB 218795 | Ki | 1221.0 [1], 8333.0 [2] |
 | Unii-G9BL4978MZ | IC50 | 5.5 [1] |
 | Unii-G9BL4978MZ | Ki | 9.55 [1] |
 | Serlopitant | IC50 | 2400.0 [1] |
 | Serlopitant | Ki | 2.4 [1] |
 | CID 9852253 | Ki | 0.6 [1], 0.64 [2] |
 | Phenyl-[(2-phenyl-quinoline-4-carbonyl)-amino]-acetic acid methyl ester | Ki | 2947.0 [1] |
 | (MePhe7)neurokinin B | Ki | 1597.0 [1] |
 | Methyl (2R)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetate | Ki | 1221.0 [1], 8333.0 [2] |
 | N-[(E,2R)-1-(4-Chlorophenyl)-5-oxo-5-[[(3R)-2-oxoazepan-3-yl]amino]pent-3-en-2-yl]-N-methyl-3,5-bis(trifluoromethyl)benzamide | IC50 | 24.0 [1] |
 | N-[1-[[(2R)-1-(3-Morpholin-4-ylpropylamino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide | Ki | 0.63 [1], 0.66 [2] |
 | (2S,5S,8R,12R)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-12-morpholin-4-yl-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 0.16 [1] |
 | (3,5-Dimethylphenyl)methyl (2S)-3-(1H-indol-3-yl)-2-(methylcarbamoylamino)propanoate | IC50 | 5000.0 [1] |
 | (2S,5S)-2-(1H-Indole-3-ylmethyl)-5-benzyl-1,4,7,10-tetraazacyclotetradecane-3,6,11,14-tetrone | Ki | 1258.93 [1] |
 | (2S,5S)-5,12-Dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 794.33 [1] |
 | (2S,5S,8R)-5-Benzyl-8-(cyclohexylmethyl)-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 316.23 [1] |
 | (2S,5S,8R)-5-Benzyl-2-(1H-indol-3-ylmethyl)-8-(naphthalen-2-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 7.94 [1] |
 | (2S,5S,8R)-5-Benzyl-8-[(3,4-difluorophenyl)methyl]-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 1.58 [1] |
 | (2S,5S,8R,12S)-12-Amino-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 3.16 [1] |
 | N-[(2S,5S,8R,12R)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-3,6,11,14-tetraoxo-1,4,7,10-tetrazacyclotetradec-12-yl]-2-morpholin-4-ylacetamide | Ki | 0.32 [1] |
 | (2S,5S,8R,13S)-13-Amino-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 3.16 [1] |
 | N-[2-(4-Chlorophenyl)-5-(cyclohexylcarbamoyl)phenyl]-3,4,5-trimethoxybenzamide | IC50 | 30.0 [1] |
 | 4-(4-Methylphenyl)-N-[1-[[(2R)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]benzamide | Ki | 0.32 [1] |
 | [(8R)-8-Methyl-3-(2-methyl-1,3-thiazol-4-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-thiophen-2-ylphenyl)methanone | Ki | 12589.25 [1], 14000.0 [2] |
 | N-[4-(4-Acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide | IC50 | 8.9 [1] |
 | N-[4-(4-Acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide | Ki | 0.6 [1] |
 | (2S,5S,8R,12S)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-12-morpholin-4-yl-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 0.79 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 30.9 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 12.7 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 107.15 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 44.2 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-aminophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 371.54 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-aminophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 156.0 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-chlorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 3467.37 [1] |
 | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-chlorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 1422.0 [1] |
 | Paclitaxel | Ki | 2042.0 [1] |
 | Cyclosporin A | Ki | 1380.0 [1] |
 | Tamoxifen | Ki | 1223.0 [1] |
 | Chlorpromazine | Ki | 9065.0 [1] |
 | Amiodarone | Ki | 6438.0 [1] |
 | Docetaxel | Ki | 521.0 [1] |
 | Ketoconazole | Ki | 5748.0 [1] |
 | Diethylstilbestrol | Ki | 3184.0 [1] |
 | Ritonavir | Ki | 874.0 [1] |
 | Lovastatin | Ki | 9408.0 [1] |
 | Raloxifene | Ki | 1330.0 [1] |
 | Vinorelbine | Ki | 535.55 [1] |
 | Clomiphene | Ki | 1508.0 [1] |
 | Indinavir | Ki | 1700.0 [1] |
 | Danazol | Ki | 8860.0 [1] |
 | Miconazole | Ki | 1613.0 [1] |
 | Clotrimazole | Ki | 3383.0 [1] |
 | Saquinavir | Ki | 2071.0 [1] |
 | Nelfinavir | Ki | 9793.0 [1] |
 | Fluphenazine | Ki | 7495.0 [1] |
 | Gentian violet | Ki | 560.0 [1] |
 | Terfenadine | Ki | 892.0 [1] |
 | Montelukast | Ki | 1274.0 [1] |
 | Hexachlorophene | Ki | 1379.7 [1] |
 | 4-Nonylphenol | Ki | 1505.0 [1] |
 | alpha-Naphthoflavone | Ki | 1949.0 [1] |
 | Astemizole | Ki | 995.0 [1] |
 | Econazole | Ki | 2011.0 [1] |
 | Metergoline | Ki | 1357.0 [1] |
 | 4-Octylphenol | Ki | 5810.0 [1] |
 | Ciglitazone | Ki | 4192.0 [1] |
 | 2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amine | IC50 | 10000.0 [1] |
 | Ebastine | Ki | 644.3 [1] |
 | Benzethonium chloride | Ki | 642.0 [1] |
 | Bithionol | Ki | 1553.0 [1] |
 | (1S,2R)-2-(Octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol | Ki | 2264.3 [1] |
 | Sulconazole | Ki | 1653.0 [1] |
 | (S)-2-(2-Benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid | Ki | 4836.0 [1] |
 | Oxiconazole | Ki | 1073.9 [1] |
 | 3-((3,5-Bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidine | IC50 | 1000.0 [1] |
 | 3-Methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide | Ki | 277.0 [1] |
 | CID 6918468 | IC50 | 87.0 [1] |
 | Haloprogin | Ki | 491.0 [1] |
 | (1S,4S,7S,10S,13S,16S)-4-Benzyl-7-(1H-indol-3-ylmethyl)-16-(2-methylpropyl)-13-(2-methylsulfanylethyl)-2,5,8,11,14,17,20-heptazabicyclo[8.8.4]docosane-3,6,9,12,15,18,21-heptone | Ki | 0.63 [1] |
 | Propan-2-yl (2S)-2-[[(2S)-2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate | Ki | 536.0 [1] |
 | Cetylpyridinium bromide | Ki | 2877.0 [1] |